Capital Performance Advisors LLP Procept Bio Robotics Corp Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 16 shares of PRCT stock, worth $1,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,476% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
223Shares Held
36.4MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$435 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$322 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$167 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$161 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$126 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.12B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...